TrialCNS drugs2012

Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

Neda Askari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.